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ABSTRACT
Background: Previous studies have suggested that psychological interventions may be effective in reducing blood pressure. Using
rigorous methodology and 24­hour monitoring of ambulatory blood pressure, we compared 2 psychological interventions with
treatment using a first­line antihypertensive drug in terms of their efficacy in lowering blood pressure in patients with mild
primary hypertension.
Methods: In this prospective, open­label randomized controlled trial (RCT), 65 adult patients with mild, uncomplicated hyper­
tension were randomly assigned to receive one of the following interventions for 12 weeks: (1) pharmacotherapy with hydro­
chlorothiazide 12.5 titrated to 25 mg/d ; (2) individualized behavioural psychotherapy, consisting of ten 1­hour sessions of stress
reduction training with a psychologist; or (3) self­help psychotherapy, consisting of a 1.5­hour session with a psychologist and
then daily sessions that involved reading a self­help manual and listening to an audiotape. The primary outcome measure was
mean change in ambulatory blood pressure from baseline to week 12. Resting blood pressure readings were taken in the clinic,
and adverse events were recorded.
Results: Monitoring of ambulatory blood pressure over 24 hours showed that hydrochlorothiazide therapy significantly reduced
both systolic and diastolic blood pressure relative to baseline, and that this reduction was significantly greater than that achieved
with either individualized behavioural psychotherapy or self­help psychotherapy (mean reduction [standard error; SE] −11.03
[2.53] / −6.06 [1.56] mm Hg v. −0.08 [2.38] / 0.29 [1.47] mm Hg v. −1.23 [2.83] / −0.71 [1.75] mm Hg, respectively; p = 0.01).
Neither form of psychological therapy significantly lowered 24­hour ambulatory blood pressure relative to baseline.
Conclusion: For patients with primary elevated blood pressure, 2 psychological interventions did not lower 24­hour ambulatory
blood pressure, whereas hydrochlorothiazide reduced blood pressure, as expected. The findings of this RCT represent an import­
ant addition to the evidence for health care practitioners and for patients seeking psychological interventions to reduce blood
pressure.
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P
ATIENTS WITH MILD PRIMARY HYPERTENSION
have a number of options to help lower their
blood pressure. Non­pharmacological options in­
clude the DASH (Dietary Approaches to Stop Hyperten­
sion) diet,
1 a low­sodium diet,
2 exercise,
3 weight loss
4
and relaxation therapies.
5 Relaxation therapies are
based on the supposition that psychological stress may
contribute to the elevation of blood pressure in some pa­
tients.
6,7 Others have suggested possible links between
stress and hypertension are elevated sympathetic tone
or vagal dysregulation.
6,8 Several systematic reviews
have evaluated the efficacy of diverse psychological and
relaxation therapies in reducing blood pressure in pa­
tients with primary hypertension as compared to no
therapy or sham therapy.
5,9­13 However, these studies
have yielded conflicting results.
It remains important to determine whether psycholo­
gical interventions lower blood pressure and the mag­
nitude of the effect, if any, as many patients might
prefer this form of therapy over drug therapy if both
were equally efficacious. We were therefore interested
in evaluating the efficacy of 2 psychological interven­
tions in lowering blood pressure: an individualized pro­
gram of behavioural therapy and a self­help program of
psychological therapy.
With the objective of rigorously assessing the effects
of these 2 psychological interventions, we compared
them with pharmacotherapy using a thiazide, a first­
line drug commonly used in the treatment of mild
primary hypertension. A large body of evidence from
randomized controlled trials (RCTs) shows that
thiazides reduce blood pressure and quantifies the mag­
nitude of their short­term effect on systolic and diastolic
blood pressure as about 9/4 mm Hg.
14 There is consider­
able value in using a drug with a known effect as a posit­
ive control for a study such as this one. As far as we
know, no previous RCTs have directly compared psycho­
logical interventions with a drug therapy control.
Methods
Design. Prospective, open­label, randomized controlled
trial.
Setting and participants. Adult patients (aged 18 years
or older) from the community, with mild hypertension
defined as resting systolic blood pressureof 140 mm Hg
or above and/or diastolic blood pressureof 90 mm Hg
or above, were eligible. Patients were excluded if they
had cardiovascular complications or any suspected med­
ical condition that might lead to an unacceptable risk of
complications resulting from uncontrolled hypertension
during the study period. Patients whose hypertension
was uncontrolled while they were taking medication
(systolic blood pressure ≥ 170 mm Hg or diastolic blood
pressure ≥ 100 mm Hg) or who had excessively high
blood pressure while they were not taking any medica­
tion (≥ 180/110 mm Hg) were also excluded. Patients
with suspected secondary hypertension were excluded,
as were those who were pregnant or anticipated being
pregnant and those with a history of allergy to, hyper­
sensitivity to, or intolerance of thiazides. Participants
were encouraged not to adopt any other changes in life­
style, diet or exercise during the trial.
Protocol. Patients who were taking medication at the
time of initial screening underwent a washout period of
3–5 weeks. Patients who met the inclusion criteria and
whose off­treatment baseline resting systolic blood
pressure in clinic was 140 mm Hg or above or whose
resting diastolic blood pressure was 90 mm Hg or above
were randomly assigned to receive 1 of the following in­
terventions for 12 weeks: (1) hydrochlorothiazide 12.5
mg/d initially and then 25 mg/d if systolic blood pres­
sure was 140 mm Hg or above or diastolic blood pres­
sure was 90 mm Hg or above after 4 weeks of
treatment; (2) individualized behavioural psychother­
apy consisting of ten 1­hour sessions with a psycholo­
gist; (3) self­help psychological therapy, consisting of
an initial 1.5­hour meeting with a psychologist and then
daily sessions that involved reading a self­help manual
and listening to an audiotape. Both of the psychological
treatments entailed learning relaxation, biofeedback
and stress management. Details of these psychological
forms of management are presented in Box 1. Conceal­
ment of allocation was achieved by centralized random­
ization conducted via telephone by the Cochrane
Hypertension Review Group coordinator at the Uni­
versity of British Columbia. This person was blinded to
patients’ identification and to characteristics other than
sex and previous use of antihypertensive drugs. Inform­
ation about these 2 characteristics was needed to allow
block randomization. The study protocol was reviewed
and approved by the institutional ethical review board
at the University of British Columbia (UBC). Written in­
formed consent was obtained from all patients.
Recruitment, clinical evaluation and follow‐up. Par­
ticipants were recruited by means of newspaper advert­
ising and/or referral by health care practitioners or
friends. This recruitment was coordinated by UBC's Be­
havioural Cardiology Laboratory (BCL). Patients who
had not previously been receiving antihypertensive
drugs but who exhibited elevated blood pressure at the
BCL were sent to the hypertension medical clinic for
confirmation of eligibility. Patients who were already
taking antihypertensive drugs were seen at the laborat­
ory and were then sent to the clinic, where blood pres­
sure was measured before and after washout, with theResearch Perez et al
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possibility of a third post­washout check in the event of
borderline blood pressure readings. All of these poten­
tial participants provided a medical history and under­
went a physical examination. A specific laboratory
assessment was ordered if considered necessary. After
enrolment, the patients attended the clinic every 4
weeks. At each visit, resting blood pressure was meas­
ured. All resting blood pressure measurements were re­
ported as the average of 5 readings, separated by
1­minute intervals, with the first reading after 5 minutes
of rest. The patient was in a seated position and the ex­
aminer was out of the room during the readings, which
were obtained with an automatic device that concealed
the measurements from the patient (oscillometric VSM­
100 automated blood pressure machine­VSM MedTech
Ltd., Vancouver, BC, Canada
15). This rigorous methodo­
logy was intended to prevent any bias in the blood pres­
sure measurements. True blinding of the patients and
investigators was not feasible in view of the type of inter­
ventions in this study. At week 7, serum levels of po­
tassium were checked for all of the patients who had
been randomly assigned to receive hydrochlorothiazide,
to detect hypokalemia, if present, and to allow the pre­
scription of a potassium­sparing diuretic if required.
Patients were instructed to report to the clinic immedi­
ately if they experienced any unusual symptoms during
the study.
Before treatment of any kind, each patient under­
went 24­hour monitoring of ambulatory blood pressure,
by means of the Spacelabs Medical ambulatory blood
pressure monitor (model 90207, Spacelabs Inc, Red­
mond, Washington, USA). For this monitoring, blood
pressure was recorded at 20­minute intervals between
8:00 a.m. and 8:00 p.m. (for daytime measurements)
and at 1­hour intervals between 8:00 p.m. and 8:00
a.m. (for nighttime measurements). The monitoring
was repeated 12 weeks later (i.e., at the end of the
study).Research Perez et al
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Outcome measures. The primary outcome measure
was the mean change in ambulatory blood pressure
from baseline to week 12. The secondary outcome meas­
ure was the mean change in resting clinic blood pres­
sure, over 12 weeks of treatment. All adverse events,
regardless of their nature, were documented, reviewed
and reported to the ethics committee.
Statistical analysis. The calculation of the sample size
was based on a previous study,
16 in which there was a 7
mm Hg (standard deviation 11 mm Hg) difference in
systolic pressure between individualized behavioural
psychotherapy and no treatment. We calculated that a
sample size of 40 patients per treatment arm would
provide 80% power at the α = 0.05 level for detection of
the above­mentioned difference in blood pressure.
However, because of the potential for dropouts, the de­
sired sample size was increased to 50 patients per treat­
ment arm. The efficacy end­points were analyzed
accordingtotheintention­to­treatprinciple.Allstatistic­
al analyses were performed using the statistical package
NCSS 2007 (LLC, Kaysville, Utah, USA). Paired Stu­
dent’s t test was used to compare variables with continu­
ous data before and after treatment within each group.
Treatment groups were compared by analysis of vari­
ance using the general linear model approach for re­
peated measurements and Tukey’s test for multiple
comparisons. Using baseline values as covariates, ana­
lysis of covariance (ANCOVA) was also performed. A p
value less than 0.05 was considered statistically signific­
ant.
Results
Study population. Recruitment for this single­centre
study began in March 2002 and ended in May 2006. Un­
fortunately, because of recruitment difficulties, the de­
sired sample size of 50 per group was not achieved. Of
the 516 patients with suspected hypertension who were
screened, 337 were not eligible because they did not
meet the study’s inclusion criteria at the initial screen­
ing. The reasons for not qualifying varied: past medical
history, desire to choose a particular treatment, re­
quired commitment of time too great, inability to come
to our centre (e.g., living far away), lack of interest in
stress management or in the drug. The remaining 179
patients were sent to the medical hypertension clinic for
evaluation. Of these, 13 patients decided not to particip­
ate after undergoing the evaluation. An additional 101
patients were ineligible for the following reasons: 65 pa­
tients did not meet the minimum blood pressure inclu­
sion criteria after the washout process, 8 patients had
excessively high blood pressure (≥180/110 mm Hg),
and 28 had a medical history that precluded their parti­
cipation (such as coronary artery disease) (Fig. 1).
A total of 65 patients (with baseline characteristics
as listed in Table 1) were randomly assigned to 1 of the
3 groups: 21 to receive hydrochlorothiazide, 23 to un­
dergo individualized behavioural psychotherapy, and 21
to perform self­help psychotherapy. Two patients in
each group acknowledged that they had sought psycho­
logical or psychiatric help in the past. One of these pa­
tients (assigned to the hydrochlorothiazide group) had
received self­help psychological therapy (in the form of
a booklet). There was no statistically significant differ­
ence in the number of patients who had previously re­
ceived hydrochlorothiazide or any other
antihypertensive drug. Except for systolic blood pres­
sure as recorded during 24­hour ambulatory monitor­
ing, which was higher for those in the self­help
psychotherapy group, the groups were similar with re­
spect to all variables (Table 1). Six patients in the hydro­
chlorothiazide group, 6 in the individualized
behavioural psychotherapy group, and 9 in the self­help
psychotherapy group withdrew from the study or did
not undergo the second 24­hour monitoring of ambu­
latory blood pressure (at 12 weeks) (Fig. 1).
Primary outcome: change in ambulatory blood pres‐
sure (24‐hour monitoring). Hydrochlorothiazide pro­
duced a statistically significant reduction in both
systolic and diastolic blood pressure during 24­hour
monitoring of ambulatory blood pressure, and this
change was greater than the changes observed with
either individualized behavioural or self­help psycholo­
gical therapy (systolic mean reduction ± standard error:
−11.03 ± 2.53 v. −0.08 ± 2.38 v. −1.23 ± 2.83 mm Hg,
respectively, p = 0.006; diastolic: −6.06 ± 1.56 v. 0.29 ±
1.47 v. −0.71 ± 1.75 mm Hg, respectively, p = 0.01;
Table 2). Neither form of psychological therapy reduced
ambulatory blood pressure, as measured by 24­hour
monitoring, relative to baseline.
Secondary outcome: change in resting clinic blood
pressure. For this outcome, we included data from all
patients with at least one blood pressure measurement
after treatment and used the weighted average from all
post­treatment blood pressure measurements for the
analysis. As such, data were available for more parti­
cipants: 19 in the hydrochlorothiazide group, 18 in the
individualized behavioural therapy group, and 16 in the
self­help therapy group. In this analysis, both hydro­
chlorothiazide therapy and individualized behavioural
psychotherapy were associated with a statistically signi­
ficant reduction (relative to baseline) in systolic and
diastolic blood pressure (Table 3). The extent of reduc­
tion in blood pressure was numerically greater in the
group receiving hydrochlorothiazide than in the other 2
groups, but the mean change in resting clinic systolic orResearch Perez et al
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diastolic blood pressure over 12 weeks showed no statist­
ically significant difference among the 3 groups.
Adverse events. A total of 5 patients withdrew because
of adverse events. Three participants experienced in­
tractable headache (1 patient in the hydro­
chlorothiazide group and 2 in the self­help therapy
group). In all 3 cases, the headache subsided after with­
drawal from the study. One patient who was receiving
hydrochlorothiazide withdrew because of a suspected al­
lergic reaction to the study medication (the patient
stopped taking the drug at day 21 because of soreness
in the tongue and lips). One patient in the self­help
therapy group withdrew because of palpitations. In ad­
dition to these 5 withdrawals, 1 patient who was receiv­
ing 25mg of hydrochlorothiazide experienced
hypokalemia, which was corrected by the addition of
spironolactone. There were no serious adverse events
during the trial.
Discussion
It has been hypothesized that psychological stress may
contribute to the elevation of blood pressure in patients
with primary hypertension, and, conversely, that psy­
chological therapy may lower blood pressure. However,
these hypotheses have been called into question by the
results of a recent Cochrane systematic review, in par­
ticular the results obtained when the analysis was lim­
ited to studies that used blinded outcome assessment.
5
In that review of relaxation therapies, 25 RCTs (n =
1198 patients) were evaluated. The authors concluded
that the effect of these therapies in lowering blood pres­
sure was questionable because of the poor quality of the
studies. In fact, when only trials using blinded outcome
assessment were included (9 RCTs, n = 498 patients),
there was no significant reduction in either systolic or
diastolic blood pressure.
5
Figure 1: Flow diagram for patients in the studyResearch Perez et al
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The current study is the first RCT to directly com­
pare psychological therapy with a standard pharmacolo­
gical antihypertensive treatment. The use of
hydrochlorothiazide as a control worked well in this
study. The drug lowered ambulatory blood pressure, as
measured by 24­hour monitoring, by about 11/6 mm
Hg, which is similar to the reduction reported in a
meta­analysis of other studies of standard­dose thiazide
given for a similar duration of therapy, 9/4 mm Hg.
14
This result demonstrates that the patients in this trial
were representative of patients in other trials studying
mild to moderate hypertension.
This study has shown that in a clinical setting where
thiazide therapy lowered blood pressure by a magnitude
similar to that expected, 2 psychological therapies did
not have this effect. This difference in outcome was par­
ticularly evident from the blood pressure data obtained
with 24­hour monitoring. In particular, the individual­
ized behavioural therapy and self­help psychotherapy
had no effect on 24­hour ambulatory systolic or diastol­
ic blood pressure.
Hydrochlorothiazide also significantly lowered rest­
ing clinic blood pressure relative to baseline. In addi­
tion, individualized behavioural psychotherapy but not
self­help psychotherapy produced a statistically signific­
ant change in resting clinic blood pressure from
baseline. For this outcome, however, there was no stat­
istically significant difference among the groups. This
lack of difference may have been due in part to the
“placebo effect” commonly observed in studies that
used in­clinic measurements of blood pressure. The
causes of this phenomenon are unknown, but participat­
ing in a study may offer the patient some reassurance
(e.g., by having the doctor’s full attention, by meeting a
psychological need), which could be enough to reduce
anxiety and stress or to provoke changes in attitudes,
which in turn might improve blood pressure readings in
the clinic setting. It is also possible that the individual­
ized behavioural psychotherapy helped patients to learn
to relax in the clinic setting, which would have offset the
“white­coat effect.” If so, this would be unlikely to have
any clinical value, as there was no reduction in ambulat­
ory blood pressure as measured by 24­hour monitoring.
This study was a good demonstration of the value of
such 24­hour monitoring. A previous study provided
evidence for the lack of a placebo effect in patients with
mild to moderate hypertension when blood pressure
was measured by 24­hour monitoring.
17 The combina­
tion of a lack of the placebo effect and the large number
of blood pressure measurements obtained increases the
power of 24­hour monitoring to identify a treatment ef­
fect, as occurred in this trial.
One of the strengths of this study was the proper ran­
domization as well as the foolproof method of conceal­
ing treatment allocation from the patients and the
investigators. Two additional strengths were the use of
an automated device for recording both ambulatory and
clinic blood pressure, and the absence of the investigat­
ors at the time of measurement. The objective of this
was to reduce subjective bias when measuring blood
pressure. A further strength of this study was that all of
the available results were used in the analysis, which
prevented any reporting bias.
One limitation of this study was the small sample
size, which was caused by difficulties in recruiting pa­
tients with newly diagnosed hypertension and by ex­
cluding a large number of previously treated patients
who did not meet the blood pressure criteria after the
washout period (65 [58%] of the 112 patients who un­
derwent washout). A second, related limitation was the
high rate of patients unavailable for the primary out­
come analysis (6/21 [29%] from the hydro­
chlorothiazide group, 6/23 [26%] from the
individualized behavioural psychotherapy group and
9/21 [43%] from the self­help therapy group). Because
we did not achieve the desired sample size and because
many patients withdrew after randomization, the
study’s power was lower than planned, and the probab­
ility of accepting the null hypothesis (i.e., type II or beta
error) was increased. Our inability to find differences
when we compared the 3 groups of clinic blood pres­
sure measurements is an example of this type II error.
This loss of power, however, did not prevent detection
of a difference between hydrochlorothiazide and either
psychological intervention by 24­hour ambulatory
measurements. A third limitation was the chance find­
ing that baseline blood pressure in the self­help psycho­
therapy group was higher than that in the
individualized behavioural psychotherapy group. This
might have reduced the opportunity for the individual­
ized behavioural psychotherapy intervention to lower
blood pressure in that group. However, when we per­
formed the post­hoc ANCOVA analysis using baseline
values as a covariate, the p values changed minimally
for both ambulatory and resting clinic blood pressure
outcomes; we therefore believe that the initial differ­
ence in blood pressure between these 2 groups probably
had little effect. Nonetheless, caution is warranted in
interpreting these results, as the trial had limited power
to prove a lack of effect of the psychological interven­
tions on the 24­hour blood pressure measurements.
When we planned our study, no information was avail­
able on the effect of psychological therapy in lowering
blood pressure relative to a pharmacological treatment.
We chose hydrochlorothiazide because, in addition to
the well­known ability of this drug to lower blood pres­
sure, the thiazides in general have the most evidence for
reductions in mortality and morbidity when used as
first­line drugs.
18 The key important finding of this
study is that compared with hydrochlorothiazide, psy­
chological therapies appeared to have no clinically im­
portant effect in lowering blood pressure over a 12­weekResearch Perez et al
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period, as assessed by 24­hour ambulatory monitoring.
These results apply to patients with mild uncomplicated
hypertension (systolic ≥ 140 and/or diastolic ≥ 90 mm
Hg).
This new information needs to be put into context
with other available RCT data. The best available evid­
ence of the effect of relaxation therapies on blood pres­
sure was provided by a recent Cochrane systematic
review. In that review, Dickinson and colleagues
5 found
that when only RCTs with blinded blood pressure meas­
urement were included, the psychological or relaxation
techniques had no statistically significant effect in redu­
cing blood pressure. This led the authors to conclude,
“In view of the poor quality of included trials and unex­
plained variation between trials, the evidence in favor of
causal association between relaxation therapy and
blood pressure reduction is weak. Some of the apparent
benefit of relaxation was probably due to aspects of
treatment unrelated to relaxation.”
5 The results of the
RCT presented here are in agreement with that conclu­
sion. If future trials of psychological interventions and
other relaxation therapies are conducted, they must
have rigorous designs to minimize bias.
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